ClinicalTrials.Veeva

Menu

Effect of Papaverine on Renal Artery Blood Flow Volume

A

Asan Medical Center

Status and phase

Completed
Phase 4

Conditions

Kidney Cancer

Treatments

Drug: Papaverine
Drug: Normal saline

Study type

Interventional

Funder types

Other

Identifiers

NCT04162834
20191111

Details and patient eligibility

About

The purpose of this study is to evaluate the effect of papaverine on renal artery blood flow after declamping of renal artery.

Full description

The purpose of this study is to evaluate the effect of papaverine on renal artery blood flow after declamping of renal artery in patients undergoing robot assisted partial nephrectomy.

Enrollment

96 patients

Sex

All

Ages

20 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients diagnosed with kidney cancer.
  • Patients undergoing robot assisted partial nephrectomy under general anesthesia
  • 20 years old ≤ age <80 years old
  • Patients who voluntarily agreed to this clinical study
  • eGFR ≥ 60 ml / min / 1.73 m2 (Chronic Kidney Disease Epidemiology Patients with Collaboration)

Exclusion criteria

  • The tumor ≥ 7 cm in size
  • Multiple renal mass
  • If the surgery plan is changed due to open
  • When surgery is performed together with other surgery
  • Multiple renal artery
  • Patients with hypersensitivity to papaverine
  • Patients with atrioventricular block
  • Pregnant and lactating women
  • Patients using levodopa
  • Refusal of patient

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

96 participants in 2 patient groups

Papaverine group
Experimental group
Description:
Immediately after the renal artery declamping, papaverine 30 mg (1 ample, 1 ml) is mixed with 5 ml of normal saline (total 6 ml) and sprinkled around the renal artery.
Treatment:
Drug: Papaverine
Normal saline group
Active Comparator group
Description:
Immediately after the renal artery declamping, normal saline 6 ml is sprinkled around the renal artery.
Treatment:
Drug: Normal saline

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems